REQUEST A DEMO
Total
USD $0.00
Search more companies

Alfa Latina S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical Equipment and Supplies Manufacturing | Other Ambulatory Health Care Services
Full name: Alfa Latina S.A.S Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Alfa Latina S.A.S is an enterprise in Colombia, with the main office in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on August 24, 2016. 7 (2026) employees currently work for Alfa Latina S.A.S. The latest financial highlights indicate a net sales revenue increase of 18.58% in 2025. Its’ total assets recorded a growth of 54.22%. The net profit margin of Alfa Latina S.A.S decreased by 0.64% in 2025.

Headquarters
Carrera 32 A # 17 - 51 Barrio San Alonso
Bucaramanga; Santander;

Contact Details: Purchase the Alfa Latina S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Alfa Latina S.A.S report to view the information.
Financial Auditors:
Purchase the Alfa Latina S.A.S report to view the information.
Incorporation Date:
August 24, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Alfa Latina S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
18.58%
Total Operating Revenue
18.58%
Net Profit/Loss for the Period
4.65%
Total Assets
54.22%
Total Equity
47.1%
Net Profit Margin
-0.64%
Return on Equity (ROE)
-13.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?